Novel Benzohydroxamate-Based Potent and Selective Histone Deacetylase 6 (HDAC6) Inhibitors Bearing a Pentaheterocyclic Scaffold: Design, Synthesis, and Biological Evaluation
作者:Barbara Vergani、Giovanni Sandrone、Mattia Marchini、Chiara Ripamonti、Edoardo Cellupica、Elisabetta Galbiati、Gianluca Caprini、Gianfranco Pavich、Giulia Porro、Ilaria Rocchio、Maria Lattanzio、Marcello Pezzuto、Malgorzata Skorupska、Paola Cordella、Paolo Pagani、Pietro Pozzi、Roberta Pomarico、Daniela Modena、Flavio Leoni、Raffaella Perego、Gianluca Fossati、Christian Steinkühler、Andrea Stevenazzi
DOI:10.1021/acs.jmedchem.9b01194
日期:2019.12.12
Histone deacetylase 6 (HDAC6) is a peculiar HDAC isoform whose expression and functional alterations have been correlated with a variety of pathologies such as autoimmune disorders, neurodegenerative diseases, and cancer. It is primarily a cytoplasmic protein, and its deacetylase activity is focused mainly on nonhistone substrates such as tubulin, heat shock protein (HSP)90, Foxp3, and cortactin, to
组蛋白脱乙酰基酶6(HDAC6)是一种特殊的HDAC亚型,其表达和功能改变已与多种病理学相关,例如自身免疫性疾病,神经退行性疾病和癌症。它主要是一种细胞质蛋白,其脱乙酰酶活性主要集中在非组蛋白底物上,例如微管蛋白,热休克蛋白(HSP)90,Foxp3和cortactin等。HDAC6的选择性抑制在健康细胞中不显示细胞毒性作用,通常与I类HDAC同工型的抑制有关。在这里,我们描述了带有五杂环中央核心的新型有效和选择性HDAC6抑制剂的设计和合成。